Company Updates

Overview Tesserent provides Internet security services to help organisations defend against cybercrime. Tesserent has developed a security infrastructure platform, known as the MSSP Platform, which enables delivery of Security-as-a-Service (also known as SECaaS) on a subscription basis to small and large organisations to protect their computer networks. Tesserent directly provides Security-as-a-Service to customers in Australia […]

2nd December 2015, ASX Announcement Highlights: Big Unlimited signs first international sales distribution license with leading US International Insights Organisation, DNA Behaviour International Resources (DNA) Exclusive agreement with DNA provides Big Review TV with access to a wide distribution network of SMEs within the U.S Agreement to accelerate membership growth within the U.S,  following earlier […]

Renewable Chemicals- US Introduces Tax Incentive Law Renewable Chemicals Act 2015 US Senators have introduced a bill to create incentives in tax policy for Industrial Biotech companies for the production of eligible renewable chemicals from biomass feedstock. Read more>> Edison Investment Research Executive Interview with Ken Richards Managing Director, Ken Richards was recently interviewed by Edison Investment Group. […]

1st December 2015, ASX Announcement Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) is pleased to announce that it has entered into a partnership with IMA Consultancy in the UK to develop an App that allows users to connect with TV stars. The new App will be initially hosted by two of the most influential […]

1st December 2015, ASX Announcement MedAdvisor raises $5m in oversubscribed public offer MedAdvisor commences trading under ticker code MDR MedAdvisor announces new medication training relationship with Amgen MedAdvisor Limited (MedAdvisor or Company) an Australian software developer focused on improving health outcomes by placing patients at the centre of connected health platforms, has been re-admitted to […]

Health-Tech Company Alcidion to List on ASX in Reverse Takeover

Alcidion Wins a 2015 Impact Award

Just to update you on DomaCom; in the last 4 weeks, Axstra Capital has raised $5.5m into their current pre-IPO round. ASX listed asset manager Contango Group has also invested $2m into this round (http://www.contango.com.au). Contango is an ASX listed fund manager, so to receive their commitment at the pre-IPO level is a major funding milestone for DomaCom. […]

30th November 2015, ASX Announcement Clinical stage oncology company Prescient Therapeutics Ltd (PTX) is delighted to announce the appointment of the H. Lee Moffitt Cancer Center’s Professor Jeffrey Lancet MD to PTX’s Scientific Advisory Board (SAB). Professor Lancet is a medical oncologist whose work involves the development and implementation of clinical trials using small molecule […]